Fig. 2From: Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseasesChange in FVC % predicted over the time. Footnotes: *this median difference was calculated comparing data of only eight patients as three patients died before the 6 months of follow-up since antifibrotics initiationBack to article page